Galapagos NV
GLPG
#4563
Rank
โ‚น189.74 B
Marketcap
โ‚น2,838
Share price
-0.57%
Change (1 day)
24.35%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚น46.41 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚น0.32 Billion. In 2024 the company made an earning of -โ‚น0.52 Billion, an increase over its 2023 earnings that were of -โ‚น3.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น46.41 Billion8838.73%
2024 -โ‚น0.52 Billion-82.77%
2023 -โ‚น3.02 Billion-85.59%
2022 -โ‚น20.92 Billion60.71%
2021 -โ‚น13.02 Billion-60.08%
2020 -โ‚น32.61 Billion-331.44%
2019 โ‚น14.08 B-523.76%
2018 -โ‚น3.33 Billion-72.34%
2017 -โ‚น12.02 Billion-329.59%
2016 โ‚น5.23 B-144.3%
2015 -โ‚น11.82 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
โ‚น1.175 T-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น2.910 T-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น817.53 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น149.12 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น8 Billion-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น731.08 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น159.19 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น837.53 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.074 T-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA